Home › Therapeutic areas › Immunology › Hereditary Angioedema
Hereditary Angioedema (3 companies)
Companies with an active program in Hereditary Angioedema.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| BCRX | Biocryst Pharmaceuticals | DermatologyImmunology+1 Rare | 2 | Approved | $1.98B | 4 |
| NTLA | Intellia Therapeutics | CardiovascularImmunology Rare | 1 | NDA Submitted | $1.59B | 3 |
| IONS | Ionis Pharmaceuticals | CardiovascularHematology+5 Rare | 1 | Approved | $6.55B | 29 |
No companies match.